Location United Kingdom, Europe Regions Europe, Middle East, and Africa (EMEA) Gender Male
Investor Type
LinkedIn View on LinkedIn
Dr. Munis is a venture capital professional with a background spanning life sciences, emerging healthcare technologies, and innovation strategy. Before joining LifeSpan Vision Ventures, he completed postdoctoral research at the University of Oxford and held scientific and strategic roles at AstraZeneca and Eisai, contributing to programs across
high-impact therapeutic areas including oncology, neurology, and immunology. His work combined deep scientific expertise with translational strategy, supporting early-stage research initiatives aimed at advancing novel therapeutics. Most recently, Dr. Munis was responsible for sourcing and evaluating investment opportunities at Eisai, with a focus on life science therapeutics, techbio, and AI. His role encompassed leading due diligence activities, conducting market and competitive landscape analyses, and building strategic networks across venture capital, biotechnology, and academic ecosystems. He also supported in-licensing and partnership activities. At LifeSpan Vision Ventures, Dr. Munis applies a multidisciplinary, data-driven approach to venture investing, with a particular focus on transformational science and therapies that advance regenerative medicine and promote longevity and healthy aging. He is committed to identifying and advancing disruptive technologies that will define the future of healthcare and human well-being.
